Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era

Open access
Serrano-Aroca, Ángel, Takayama, Kazuo, Tuñón-Molina, Alberto, Seyran, Murat, Hassan, Sk. Sarif, Pal Choudhury, Pabitra, Uversky, Vladimir N., Lundstrom, Kenneth, Adadi, Parise, Palù, Giorgio, Aljabali, Alaa A. A., Chauhan, Gaurav, Kandimalla, Ramesh, Tambuwala, Murtaza M., Lal, Amos, Abd El-Aziz, Tarek Mohamed, Sherchan, Samendra, Barh, Debmalya, Redwan, Elrashdy M., Bazan, Nicolas G., Mishra, Yogendra Kumar, Uhal, Bruce D., Brufsky, Adam · 2021 · ACS Nano

Abstract

Therapeutic options for the highly pathogenic human Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) causing the current pandemic Coronavirus disease (COVID-19) are urgently needed. COVID-19 is associated with viral pneumonia and acute respiratory distress syndrome causing significant morbidity and mortality. The proposed treatments for COVID-19, such as hydroxychloroquine, remdesivir and lopinavir/ritonavir, have shown little or no effect in the clinic. Additionally, bacterial and fungal pathogens contribute to the SARS-CoV-2 mediated pneumonia disease complex. The antibiotic resistance in pneumonia treatment is increasing at an alarming rate. Therefore, carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives constitute a promising alternative due to their wide-spectrum antimicrobial activity, biocompatibility, biodegradability and capacity to induce tissue regeneration. Furthermore, the antimicrobial mode of action is mainly physical (e.g. membrane distortion), which is characterized by a low risk of antimicrobial resistance. In this review, we evaluated the literature on the antiviral activity and broad-spectrum antimicrobial properties of CBNs. CBNs had antiviral activity against 12 enveloped positive-sense single-stranded RNA viruses similar to SARS-CoV-2. CBNs with low or no toxicity to the humans are promising therapeutics against COVID-19 pneumonia complex with other viruses, bacteria and fungi, including those that are multidrug-resistant.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsnano.1c00629

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 181

Metadata

Authors
Serrano-Aroca, Á., Takayama, K., Tuñón-Molina, A., Seyran, M., Hassan, S. S., Pal Choudhury, P., Uversky, V. N., Lundstrom, K., Adadi, P., Palù, G., Aljabali, A. A. A., Chauhan, G., Kandimalla, R., Tambuwala, M. M., Lal, A., Abd El-Aziz, T. M., Sherchan, S., Barh, D., Redwan, E. M., Bazan, N. G., Mishra, Y. K., Uhal, B. D., & Brufsky, A.
Venue
ACS Nano
Published
2021-04-07
Volume
15
Issue
5
Pages
8069-8086
ISSN
  • 1936-0851 (ISSN-L)
  • 1936-086X
OpenAlex
W3149600433
Cited by
181
References
2
FWCI
11.34
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era. https://app.cochat.ai/papers/10.1021/acsnano.1c00629
The paper
Serrano-Aroca, Á., Takayama, K., Tuñón-Molina, A., Seyran, M., Hassan, S. S., Pal Choudhury, P., Uversky, V. N., Lundstrom, K., Adadi, P., Palù, G., Aljabali, A. A. A., Chauhan, G., Kandimalla, R., Tambuwala, M. M., Lal, A., Abd El-Aziz, T. M., Sherchan, S., Barh, D., Redwan, E. M., . . . Brufsky, A. (2021). Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era. ACS Nano. https://doi.org/10.1021/acsnano.1c00629

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.